22.71

3.18% 0.70

Pre-market: 23.05 0.34 +1.50%

Tectonic Therapeutic Inc (TECX)

Overview News Price History Discussions Forecast

Tectonic Therapeutic Inc stock is traded at $22.71, with a volume of 702.12K. It is up +3.18% in the last 24 hours and up +15.87% over the past month. Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

Previous Close:

$22.01

Open:

$23.46

24h Volume:

702.12K

Relative Volume:

1.83

Market Cap:

$425.05M

Revenue:

Net Income/Loss:

$-67.30M

P/E Ratio:

-5.8981

EPS:

-3.8504

Net Cash Flow:

$-62.65M

1W Performance:

-0.66%

1M Performance:

+15.87%

6M Performance:

+3.79%

1Y Performance:

-28.13%

1-Day Range:

$22.36

$24.61

1-Week Range:

$16.77

$25.00

52-Week Range:

$13.70

$36.11

Tectonic Therapeutic Inc Stock (TECX) Company Profile

Name

Tectonic Therapeutic Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

(339) 666-3320

Address

490 ARSENAL WAY, WATERTOWN

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

TECX's Discussions on Twitter

Compare TECX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TECX Tectonic Therapeutic Inc	22.71	411.95M	0	-67.30M	-62.65M	-3.8504
VRTX Vertex Pharmaceuticals Inc	465.02	117.03B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.65	82.35B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	833.54	51.64B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	308.48	42.58B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	346.42	38.87B	4.98B	69.60M	525.67M	0.5198

Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Wells Fargo	Overweight
Sep-03-25	Initiated	Oppenheimer	Outperform
Jul-21-25	Initiated	Truist	Buy
Jun-11-25	Resumed	Raymond James	Outperform
Apr-21-25	Initiated	Mizuho	Outperform
Nov-20-24	Initiated	Raymond James	Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Jun-26-24	Initiated	Piper Sandler	Overweight
Jun-24-24	Initiated	TD Cowen	Buy
Dec-18-23	Downgrade	Mizuho	Buy → Neutral
Jan-05-22	Downgrade	BTIG Research	Buy → Neutral
Nov-19-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-15-21	Initiated	BTIG Research	Buy
May-27-21	Initiated	Needham	Buy
Mar-09-21	Initiated	Barclays	Overweight
Mar-02-21	Initiated	Stifel	Hold
Nov-11-20	Initiated	Berenberg	Buy
Mar-31-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-27-19	Initiated	Mizuho	Buy
Apr-05-19	Initiated	Janney	Buy
Oct-10-18	Initiated	Guggenheim	Buy
Oct-02-18	Reiterated	H.C. Wainwright	Buy
Sep-17-18	Initiated	H.C. Wainwright	Buy
Jul-16-18	Initiated	Wedbush	Outperform
Jul-16-18	Initiated	Wells Fargo	Outperform

View All

Tectonic Therapeutic Inc Stock (TECX) Latest News

03:15 AM

Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

03:15 AM

Feb 11, 2026

Insider Buying: Daniel Lochner Acquires Additional Shares of Tec - GuruFocus

Feb 11, 2026

Tectonic Therapeutic (NASDAQ:TECX) CFO Daniel Lochner Purchases 6,000 Shares - MarketBeat

Feb 11, 2026

Aug Patterns: Is Tectonic Therapeutic Inc subject to activist investor interestWeekly Volume Report & Daily Entry Point Trade Alerts - baoquankhu1.vn

Feb 09, 2026

What is Lifesci Capital's Forecast for TECX FY2025 Earnings? - MarketBeat

Feb 09, 2026

What is Lifesci Capital’s Forecast for TECX FY2025 Earnings? - Defense World

Feb 09, 2026

Feb 08, 2026

Risk Hedge: Does Tectonic Therapeutic Inc have declining or rising EPS2025 Valuation Update & Weekly High Conviction Ideas - baoquankhu1.vn

Feb 08, 2026

Feb 07, 2026

Aug Selloffs: Does Tectonic Therapeutic Inc have declining or rising EPSMarket Growth Summary & Weekly Market Pulse Alerts - baoquankhu1.vn

Feb 07, 2026

Lifesci Capital Upgrades Tectonic Therapeutic (NASDAQ:TECX) to “Strong-Buy” - Defense World

Feb 07, 2026

Feb 06, 2026

Tectonic Therapeutic (NASDAQ:TECX) Upgraded to "Strong-Buy" at Lifesci Capital - MarketBeat

Feb 06, 2026

S P Trends: Is Tectonic Therapeutic Inc stock a smart retirement pickExit Point & Daily Profit Focused Screening - baoquankhu1.vn

Feb 06, 2026

Feb 04, 2026

Aug Sentiment: Can Tectonic Therapeutic Inc. outperform under higher oil prices2025 Dividend Review & AI Based Trade Execution Alerts - baoquankhu1.vn

Feb 04, 2026

Aug Retail: Is Tectonic Therapeutic Inc subject to activist investor interestPortfolio Update Summary & Safe Entry Point Identification - baoquankhu1.vn

Feb 04, 2026

Feb 03, 2026

IPO Launch: What is the PEG ratio of Tectonic Therapeutic Inc2025 Analyst Calls & Long-Term Investment Growth Plans - baoquankhu1.vn

Feb 03, 2026

Insiders In Tectonic Therapeutic Still Down 37% On US$51.1m Investment - simplywall.st

Feb 03, 2026

Jan 31, 2026

Aug Movers: What is STROs market positionJuly 2025 Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Jan 31, 2026

Jan 30, 2026

Is now the right time to enter Tectonic Therapeutic IncMarket Growth Report & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Jan 30, 2026